Literature DB >> 25603439

Autologous serum eye drops for the treatment of ocular surface disease.

Amir A Azari1, Christopher J Rapuano.   

Abstract

OBJECTIVE: To examine the evidence for the role of autologous serum eye drops (ASD) in disease of the ocular surface.
METHODS: A search of the literature published through May 2014 using PubMed, the ISI Web of Knowledge database, and the Cochrane Library was performed. Qualified articles were selected after review of titles, abstracts, and references.
RESULTS: There was a significant improvement in either symptoms or some of the clinical examination findings, including tear breakup time, corneal staining, Schirmer values, and impression cytology in eyes with persistent corneal epithelial defect, graft-versus-host disease, Sjögren- and non-Sjögren-related dry eye disease, limbal stem-cell deficiency, recurrent corneal erosion, superior limbic keratoconjunctivitis, and postrefractive surgery. However, most of the studies were nonrandomized in nature.
CONCLUSIONS: Despite the paucity of strong supporting evidence from randomized double-masked clinical studies, there seems to be a trend toward superiority of ASD in alleviating some of the clinical signs and symptoms associated with corneal pathology in a variety of conditions that affect the ocular surface compared with conventional lubricating drops/ointments.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25603439     DOI: 10.1097/ICL.0000000000000104

Source DB:  PubMed          Journal:  Eye Contact Lens        ISSN: 1542-2321            Impact factor:   2.018


  14 in total

Review 1.  Strategies for reconstructing the limbal stem cell niche.

Authors:  Ghasem Yazdanpanah; Zeeshan Haq; Kai Kang; Sayena Jabbehdari; Mark L Rosenblatt; Ali R Djalilian
Journal:  Ocul Surf       Date:  2019-01-08       Impact factor: 5.033

2.  Application of autologous serum eye drops after pterygium surgery: a prospective study.

Authors:  Sabahattin Sul; Safak Korkmaz; Goksu Alacamli; Pelin Ozyol; Erhan Ozyol
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-07-18       Impact factor: 3.117

3.  The Role of Multisystem Disease in Composition of Autologous Serum tears and ocular surface symptom improvement.

Authors:  Madeline Ripa; Sayena Jabbehdari; Ghasem Yazdanpanah; Emoke Lukacs; Brandon Karcher; Omer Iqbal; Charles Bouchard
Journal:  Ocul Surf       Date:  2020-02-29       Impact factor: 5.033

4.  Degeneration and Regeneration of Subbasal Corneal Nerves after Infectious Keratitis: A Longitudinal In Vivo Confocal Microscopy Study.

Authors:  Rodrigo T Müller; Farshad Abedi; Andrea Cruzat; Deborah Witkin; Neda Baniasadi; Bernardo M Cavalcanti; Arsia Jamali; James Chodosh; Reza Dana; Deborah Pavan-Langston; Pedram Hamrah
Journal:  Ophthalmology       Date:  2015-08-06       Impact factor: 12.079

5.  Emerging Approaches for Ocular Surface Regeneration.

Authors:  Ghasem Yazdanpanah; Sayena Jabbehdari; Ali R Djalilian
Journal:  Curr Ophthalmol Rep       Date:  2019-01-17

6.  Solvent/Detergent Virally Inactivated Serum Eye Drops Restore Healthy Ocular Epithelium in a Rabbit Model of Dry-Eye Syndrome.

Authors:  Ching-Li Tseng; Zhi-Yu Chen; Ting-Yi Renn; Shun-Hung Hsiao; Thierry Burnouf
Journal:  PLoS One       Date:  2016-04-21       Impact factor: 3.240

7.  Undiluted Serum Eye Drops for the Treatment of Persistent Corneal Epitheilal Defects.

Authors:  Kaevalin Lekhanont; Passara Jongkhajornpong; Thunyarat Anothaisintawee; Varintorn Chuckpaiwong
Journal:  Sci Rep       Date:  2016-12-02       Impact factor: 4.379

Review 8.  Systematic review of randomized controlled trials in the treatment of dry eye disease in Sjogren syndrome.

Authors:  Kendrick Co Shih; Christie Nicole Lun; Vishal Jhanji; Bernard Yu-Hor Thong; Louis Tong
Journal:  J Inflamm (Lond)       Date:  2017-11-21       Impact factor: 4.981

Review 9.  Human Serum Eye Drops in Eye Alterations: An Insight and a Critical Analysis.

Authors:  Maria Rosaria De Pascale; Michele Lanza; Linda Sommese; Claudio Napoli
Journal:  J Ophthalmol       Date:  2015-10-04       Impact factor: 1.909

10.  Corneal Epithelial Stem Cell Supernatant in the Treatment of Severe Dry Eye Disease: A Pilot Study.

Authors:  Sloan W Rush; Jennifer Chain; Hiranmoy Das
Journal:  Clin Ophthalmol       Date:  2021-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.